​​​​​​

Jonathan Rowe, Executive Director, Head of Clinical Development Quality Performance and Risk Management, PFIZER

Stacy St. John, Director, Clinical Development Quality, GCP Quality Management Lead, PFIZER

Sheila Gwizdak, MS, Vice President, Quality, HALLORAN CONSULTING GROUP

Kathy Goldstein, Senior Director, Quality Management Lead, REGENERON PHARMACEUTICALS

Liz Wool, President, WOOL CONSULTING GROUP, INC.

Maryann Livolsi, MSN, RN, Senior Director, GCP Quality Assurance, BILL & MELINDA GATES MEDICAL RESEARCH INSTITUTE

Cheryl McCarthy, Director, Research Quality Assurance, IRONWOOD PHARMACEUTICALS

Jane Wood, Quality Center of Excellence Lead, YOUR ENCORE; Former Vice President and Head, BioResearch and Quality Compliance, JOHNSON & JOHNSON

Blake Jensen, Vice President, Quality and Compliance, G1 THERAPEUTICS, INC.

Christine Sahagian, Vice President, Clinical Quality Assurance and Compliance, APELLIS

Kenneth A. Getz, MBA, Director of Sponsored Programs, Associate Professor, TUFTS CENTER FOR THE STUDY OF DRUG DEVELOPMENT

Dennis Salotti, Chief Operating Officer, THE AVOCA GROUP

Michael Torok, Ph.D., Clinical Quality Assurance Head, ASTELLAS

Steve Young, Chief Operations Officer, CLUEPOINTS

Marion Mays, Vice President, Client Solutions and Quality Assurance, PHLEX GLOBAL

Sheila Gwizdak, Principal Consultant, Quality, HALLORAN CONSULTING GROUP

Krista Tibbs, Specialist, Clinical Development, HALLORAN CONSULTING GROUP

Dawn M. Niccum, RN/MS, RQAP-GCP, CCRA, PMP, Senior Director, Quality Assurance and Compliance, INSEPTION GROUP

Shelly Weeks-Townsend, MS, CQA, Director, Quality Assurance, ZYNERBA PHARMACEUTICALS